NCT04723485 Evaluation Study: Obsessive-compulsive Disorders in Childhood and Young Adulthood
| NCT ID | NCT04723485 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Susanne Walitza |
| Condition | Obsessive-compulsive Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 625 participants |
| Start Date | 2020-05-01 |
| Primary Completion | 2026-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 625 participants in total. It began in 2020-05-01 with a primary completion date of 2026-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Obsessive-compulsive disorders are very damaging illnesses that can already manifest in childhood and adolescence. With an average prevalence from 1 - 3%, they are one of the most frequently diagnosed psychiatric illness in these age groups. With the further use of data, the treatment success can be significantly improved; causal variables/predictors can be recognized, understood and taken carefully into account. The anticipated incremental knowledge will ultimately help children and young people with obsessive-compulsive disorders to receive faster and more effective treatment.
Eligibility Criteria
Inclusion Criteria: * Children and young people from 8-18 years of age who fulfill the international classification of diseases tenth edition (ICD-10) , obsessive-compulsive disorder handled in our clinic. * Good German language speaking skills * IQ \> 75 * All study participants or their legal representative have given written permission for their experiences to be documented in the study. Exclusion Criteria: * Schizophrenia-related disorders (psychoses) * Missing data * Data sets without confirmed diagnosis * Purely consultaive patient interview (no therapy intervention prescribed)
Contact & Investigator
Susanne Walitza, Prof. Dr. med. Dipl.-Psych.
PRINCIPAL INVESTIGATOR
Sponsor-Investigator
Frequently Asked Questions
Who can join the NCT04723485 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 18 Years, studying Obsessive-compulsive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04723485 currently recruiting?
Yes, NCT04723485 is actively recruiting participants. Contact the research team at susanne.walitza@puk.zh.ch for enrollment information.
Where is the NCT04723485 trial being conducted?
This trial is being conducted at Zurich, Switzerland.
Who is sponsoring the NCT04723485 clinical trial?
NCT04723485 is sponsored by Susanne Walitza. The principal investigator is Susanne Walitza, Prof. Dr. med. Dipl.-Psych. at Sponsor-Investigator. The trial plans to enroll 625 participants.